Breaking News Instant updates and real-time market news.

GS

Goldman Sachs

$228.66

-0.93 (-0.41%)

, AB

AllianceBernstein

$28.92

0.48 (1.69%)

04:55
11/06/18
11/06
04:55
11/06/18
04:55

BofA/Merrill to hold a conference

Future of Financials Conference will be held in New York on November 5-6.

GS

Goldman Sachs

$228.66

-0.93 (-0.41%)

AB

AllianceBernstein

$28.92

0.48 (1.69%)

HBAN

Huntington Bancshares

$14.37

0.09 (0.63%)

NDAQ

Nasdaq

$88.78

1.84 (2.12%)

NYCB

New York Community Bancorp

$9.69

0.055 (0.57%)

USB

U.S. Bancorp

$52.35

0.3 (0.58%)

STT

State Street

$71.91

2.01 (2.88%)

WFC

Wells Fargo

$53.66

0.06 (0.11%)

ETFC

E-Trade

$51.44

0.33 (0.65%)

BX

Blackstone

$33.83

0.63 (1.90%)

CBOE

Cboe Global Markets

$111.90

-0.37 (-0.33%)

C

Citi

$67.30

1.4 (2.12%)

AXP

American Express

$105.20

1.51 (1.46%)

KKR

KKR

$24.00

0.13 (0.54%)

JPM

JPMorgan

$109.08

0.79 (0.73%)

MS

Morgan Stanley

$45.82

-0.12 (-0.26%)

FRC

First Republic

$92.91

0.71 (0.77%)

EV

Eaton Vance

$44.71

-0.7 (-1.54%)

  • 06

    Nov

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 07

    Nov

  • 08

    Nov

  • 11

    Nov

  • 13

    Nov

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 03

    Dec

  • 14

    Jan

  • 26

    Feb

  • 12

    Apr

  • 15

    Apr

  • 13

    Jul

  • 13

    Jul

  • 12

    Oct

GS Goldman Sachs
$228.66

-0.93 (-0.41%)

10/17/18
BMOC
10/17/18
NO CHANGE
Target $276
BMOC
Market Perform
Goldman Sachs price target raised to $276 from $261 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on Goldman Sachs to $276 after its Q3 earnings beat, with results featuring higher than expected investment banking fees and a "strong showing" from its incoming CFO Stephen Scherr. The analyst notes that financials are "cheap again" in spite of the rising short-term rates, improving employment, and continued regulatory relief. Fotheringham also keeps his Market Perform rating on Goldman Sachs on valuation, noting that its two-year foward PE multiple is "only slightly" below its long-term historical average.
10/16/18
JMPS
10/16/18
NO CHANGE
JMPS
Market Perform
JMP Securities sees Goldman Sachs Q3 results as 'solid'
JMP Securities analyst Devin Ryan says Goldman Sachs Q3 results were "solid,' in aggregate, against a seasonally slow backdrop. Nonetheless, the analyst suspects the Street could pick a bit at several items, such as the lower tax rate, lower comp ratio, or modest underperformance in FICC trading. Taking a step back, Ryan believes the market should be encouraged by the 13% return on equity. He reiterates a Market Perform rating on the shares.
09/25/18
WOLF
09/25/18
INITIATION
Target $290
WOLF
Outperform
Goldman Sachs initiated with an Outperform at Wolfe Research
Wolfe Research analyst Steven Chubak initiated Goldman Sachs with an Outperform and $290 price target.
09/19/18
OPCO
09/19/18
NO CHANGE
OPCO
Outperform
U.S. banks 'in very good shape,' says Oppenheimer, favorites include BofA, Citi
Oppenheimer analyst Chris Kotowski tells investors in a research note that the U.S. banking group is on solid footing with balance sheets less risky than at any time over the last 33 years the firm covered the group and says his favorite bank stocks are Outperform-rated Bank of America (BAC), Citi (C), CIT (CIT) and Goldman Sachs (GS). However, Kotowski notes that banks are trading at an average relative P/E of just ~66% relative to the S&P 500 and returning to a historical avg valuation of 73%-80% range would imply over a thousand basis points of outperformance by the group. In his view, the U.S. banks are, on the whole, in "very good" shape.
AB AllianceBernstein
$28.92

0.48 (1.69%)

HBAN Huntington Bancshares
$14.37

0.09 (0.63%)

06/29/18
06/29/18
NO CHANGE

Goldman says Wells Fargo, Huntington, Regions among biggest winners of CCAR
Goldman Sachs analyst Richard Ramsden said the Fed's CCAR results came in largely better than expected, calling Wells Fargo (WFC), Huntington Bancshares (HBAN), Regions Financial (RF), SunTrust (STI) and Fifth Third (FITB) the biggest relative winners in his view. He believes the market will be focused on banks' 25% dividend growth announcements and believes the CCAR results can be a catalyst for a relief rally.
06/29/18
DBAB
06/29/18
NO CHANGE
DBAB
Deutsche declares Wells Fargo, SunTrust, Huntington the CCAR winners
Deutsche Bank analyst Matt O'Connor views Wells Fargo (WFC), SunTrust (STI) and Huntington Bancshares (HBAN) as the winners of the Federal Reserve's Comprehensive Capital Analysis and Review. The banks separately disclosed planned dividend increases and buybacks for the next four quarters, O'Connor tells investors in a research note. He points out that while JPMorgan (JPM), KeyCorp (KEY) and M&T Bank (MTB) "all used the mulligan," he does not view this as negative.
11/02/18
WEDB
11/02/18
DOWNGRADE
Target $16
WEDB
Neutral
Huntington Bancshares downgraded to Neutral from Outperform at Wedbush
Wedbush analyst Peter Winter downgraded Huntington Banchsares to Neutral from Outperform based on valuation. Winter also lowered his price target to $16 from $18 to reflect lower EPS estimates. In a research note to investors, Winter says his investment thesis has played out and its valuation has re-rated as the stock is up 52% since April 5, 2016 and now trades at a slight premium to its regional bank peers.
11/02/18
WEDB
11/02/18
DOWNGRADE
WEDB
Neutral
Huntington Bancshares downgraded to Neutral from Outperform at Wedbush
NDAQ Nasdaq
$88.78

1.84 (2.12%)

09/05/18
09/05/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Universal Display (OLED) initiated with a Buy at Citi. 2. Bio-Rad (BIO) initiated with an Equal Weight at Barclays. 3. Amalgamated Bank (AMAL) initiated with an Overweight at Barclays. 4. Pacific City Financial (PCB) initiated with a Buy at Sandler O'Neill. 5. Nasdaq (NDAQ) initiated with a Neutral at Rosenblatt. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/22/18
COMP
06/22/18
INITIATION
Target $100
COMP
Neutral
Nasdaq initiated with a Neutral at Compass Point
Compass Point initiated Nasdaq with a Neutral and $100 price target.
09/05/18
RSBL
09/05/18
INITIATION
Target $99
RSBL
Neutral
Nasdaq initiated with a Neutral at Rosenblatt
Rosenblatt analyst Ken Hill initiated Nasdaq with a Neutral and $99 price target saying 2018 appears to be a relatively disappointing year from a results perspective, but investments made this year should help elevate future earnings. Hill believes management will be successful on Nasdaq's transformation but recommends investors look for a better entry point.
06/22/18
WELS
06/22/18
NO CHANGE
Target $104
WELS
Outperform
Nasdaq price target raised to $104 from $95 at Wells Fargo
Wells Fargo analyst Christopher Harris raised his price target for Nasdaq to $104 after hosting investor meetings with management. The analyst left feeling more confident that the company can achieve its higher growth targets, at least over a medium term basis. He suspects the realization of these targets will be good for the stock and reiterates an Outperform rating on Nasdaq.
NYCB New York Community Bancorp
$9.69

0.055 (0.57%)

08/28/18
FBCO
08/28/18
INITIATION
Target $12
FBCO
Neutral
New York Community Bancorp reinstated with a Neutral at Credit Suisse
Credit Suisse analyst Moshe Orenbuch reinstated coverage of New York Community Bancorp with a Neutral rating and $12 price target. The analyst believes the company will continue to face NIM pressure for the next 1-2 years owing to the fixed-rate nature of most of its loans and continued competition in the deposit market. This should continue to pressure the company's ROE, a trend he has seen for several years.
10/26/18
PIPR
10/26/18
UPGRADE
Target $9
PIPR
Neutral
New York Community upgraded to Neutral from Underweight at Piper Jaffray
Piper Jaffray analyst Matthew Breese upgraded New York Community Bancorp to Neutral while lowering his price target for the shares to $9 from $10. Following the company's Q3 results, the analyst still has fundamental concerns with the outlook of the net interest margin given the bank's funding profile, in addition to the bank's capital position and dividend payout ratio. However, with the stock down 30% year-to-date and a "'safe-for-now dividend," the analyst is moving to the sidelines.
03/22/18
UBSW
03/22/18
INITIATION
Target $12
UBSW
Sell
New York Community Bancorp initiated with a Sell at UBS
UBS analyst Brock Vandervliet started New York Community Bancorp with a Sell rating and $12 price target. The analyst rolled out coverage last night on the Mid-Cap Banks. He sees performance differentiation "playing out more starkly" than investors may expect with "increasingly advantaged and disadvantaged participants."
03/21/18
UBSW
03/21/18
INITIATION
UBSW
Sell
New York Community Bancorp initiated with a Sell at UBS
USB U.S. Bancorp
$52.35

0.3 (0.58%)

10/18/18
10/18/18
UPGRADE
Target $62

Outperform
U.S.Bancorp upgraded to Outperform on positive operating leverage at Oppenheimer
As previously reported, Oppenheimer analyst Chris Kotowski upgraded U.S. Bancorp to Outperform from Perform, with a $62 price target. The analyst notes that since rates started rising in late 2015, USB has started seeing accelerating core earnings growth again, but the growth rate has slightly lagged behind peers' as a result of modestly negative operating leverage. Q3 brought the second consecutive quarter of positive operating leverage, and he thinks U.S. Bancorp is now well poised to outperform.
10/18/18
OPCO
10/18/18
UPGRADE
OPCO
Outperform
U.S. Bancorp upgraded to Outperform from Perform at Oppenheimer
10/31/18
MSCO
10/31/18
NO CHANGE
MSCO
Morgan Stanley sees BB&T, AmEx as possible winners if Fed changes bank rules
Noting that the Federal Reserve will release a memo detailing proposed changes to bank capital rules to the public around 10 am today and is scheduled to vote on this proposal in a meeting starting at 10:30 am, Morgan Stanley analyst Betsy Graseck said BB&T (BBT) could be the biggest beneficiary with a 5% EPS increase if it is ruled that banks with more than $250B in assets that are not Global Systemically Important Banks should have more tailored regulation. Other potential beneficiaries of possible rule changes include American Express (AXP), Capital One (COF), Northern Trust (NTRS), PNC Financial (PNC) and U.S. Bancorp (USB), Graseck added.
11/02/18
SBSH
11/02/18
DOWNGRADE
SBSH
Neutral
U.S. Bancorp downgraded to Neutral from Buy at Citi
Citi analyst Keith Horowitz downgraded U.S. Bancorp to Neutral.
STT State Street
$71.91

2.01 (2.88%)

10/11/18
GSCO
10/11/18
INITIATION
Target $105
GSCO
Buy
State Street initiated with a Buy at Goldman Sachs
Goldman Sachs analyst Alexander Blostein reinstated State Street with a Buy and $105 price target saying CRD acquisition risks are reflected in valuation, but earnings upside is not.
09/25/18
WOLF
09/25/18
INITIATION
Target $97
WOLF
Peer Perform
State Street initiated with a Peer Perform at Wolfe Research
Wolfe Research analyst Steven Chubak initiated State Street with a Peer Perform and $97 price target.
09/10/18
MSCO
09/10/18
UPGRADE
MSCO
Overweight
State Street upgraded to Overweight from Equal Weight at Morgan Stanley
10/22/18
RBCM
10/22/18
NO CHANGE
Target $95
RBCM
Sector Perform
State Street price target lowered to $95 from $105 at RBC Capital
RBC Capital analyst Gerard Cassidy lowered his price target on State Street (STT) to $95 and kept his Sector Perform rating after its "weak" Q3 results and limited visibility into 2019, also lowering his FY19 EPS view to $1.88 from $2.01. The analyst cites lower than expected profitability metrics that included a 10bp decline in the core ROAA as well as the company's 4.6% shortfall in non-interest income. Cassidy added that State Street is facing continued headwinds of a strengthening USD and the loss of BlackRock (BLK) business weigh on its servicing revenues.
WFC Wells Fargo
$53.66

0.06 (0.11%)

10/15/18
BMOC
10/15/18
NO CHANGE
Target $65
BMOC
Market Perform
Wells Fargo price target raised to $65 from $61 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on Wells Fargo to $65 in spite of its Q3 revenue miss as he raises his FY19 EPS view by 1c to $5.23 to reflect lower expected credit costs. The analyst also notes that financials are "cheap again" in spite of the rising interest rates which are positive for net interest margins, better employment which is positive for credit, and regulatory relief which is positive for their capital position. Fotheringham also keeps his Market Perform rating on Wells Fargo, saying that while the bank's valuation is getting "cheap" for the first time since he launched coverage, better opportunities exist in other large-cap financials.
10/15/18
10/15/18
UPGRADE
Target $62

Outperform
Wells Fargo upgraded to Outperform, visibility improving, says Macquarie
As previously reported, Macquarie upgraded Wells Fargo to Outperform from neutral with a $62 price target. Analyst David Konrad said Wells Fargo shares are trading at a 10% discount to peers and believes investors will warm up to the company's self-help story of meaningful expense savings over the next two years combined with better than peer buybacks. Konrad notes revenue growth will be challenging, but is encouraged by signs from consumers in the form of improved checking account and card growth, and moderating FA turnover.
10/15/18
MACQ
10/15/18
UPGRADE
MACQ
Outperform
Wells Fargo upgraded to Outperform from Neutral at Macquarie
11/02/18
SBSH
11/02/18
UPGRADE
SBSH
Buy
Wells Fargo upgraded to Buy from Neutral at Citi
Citi analyst Keith Horowitz upgraded Wells Fargo to Buy.
ETFC E-Trade
$51.44

0.33 (0.65%)

10/30/18
10/30/18
DOWNGRADE
Target $64

Outperform
E-Trade downgraded to Outperform, sale off the table, says Raymond James
As previously reported, Raymond James downgraded E-Trade to Outperform from Strong Buy and maintained a $64 price target. Analyst Patrick O'Shaughnessy said the recent board decision not to sell the business and remain a standalone company takes a sales scenario off the table. The analyst remains positive on shares ans believes there is plenty of upside as management executes on its operating plan.
11/02/18
WOLF
11/02/18
UPGRADE
WOLF
Outperform
E-Trade upgraded to Outperform from Peer Perform at Wolfe Research
10/30/18
10/30/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. LabCorp (LH) downgraded to Hold from Buy at Argus with analyst Jasper Hellweg saying the company is faced with pressure from "lower lab testing payment rates mandated by the Protecting Access to Medicaid Act of 2014" along with business disruptions and the impact of acquisitions which resulted in lowers margins for the quarter. 2. E-Trade (ETFC) downgraded to Outperform from Strong Buy at Raymond James with analyst Patrick O'Shaughnessy saying the recent board decision not to sell the business and remain a standalone company takes a sales scenario off the table. The analyst remains positive on shares ans believes there is plenty of upside as management executes on its operating plan. 3. Southwest (LUV) downgraded to Underweight from Neutral at JPMorgan while United Continental (UAL) and Spirit Airlines (SAVE) downgraded to Neutral from Overweight. 4. Flex (FLEX) downgraded to Hold from Buy at Argus with analyst Jim Kelleher citing the expected impact from the "shutdown of Mexican operations with key customer Nike (NKE), which he expects to be fully unwound," as well as the retirement of the company CEO Mike McNamara who had presided over the company's business expansion. 5. Elevate Credit (ELVT) downgraded to Market Perform from Outperform at JMP Securities and William Blair. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/30/18
RAJA
10/30/18
DOWNGRADE
RAJA
Outperform
E-Trade downgraded to Outperform from Strong Buy at Raymond James
BX Blackstone
$33.83

0.63 (1.90%)

09/24/18
MSCO
09/24/18
NO CHANGE
Target $48
MSCO
Overweight
Blackstone price target raised to $48 from $42 at Morgan Stanley
Morgan Stanley analyst Michael Cyprys said he came away from Blackstone's investor day more positive on the company's superior AUM and fee growth and ability to innovate. Blackstone also said a C-Corp conversion is under active consideration, which is a more positive stance than in it has expressed in the past, Cyprys tells investors. Based on expectations for strong growth in AUM, management fees and performance fee, along with the rising prospects for C-Corp conversion, Cyprys raised his price target on Blackstone shares to $48 from $42 and keeps an Overweight rating on the stock.
09/24/18
SBSH
09/24/18
NO CHANGE
Target $47.5
SBSH
Buy
Blackstone price target raised to $47.50 from $43 at Citi
Citi analyst William Katz raised his price target for Blackstone to $47.50 following last week's investor day. The analyst left constructive on the Alternatives sector and impressed by the "multitude of earnings drivers" at Blackstone. He's encouraged by the company's "growing competitive moat and longer-term opportunities" and keeps a Buy rating on the shares.
09/25/18
ARGS
09/25/18
NO CHANGE
Target $46
ARGS
Buy
Blackstone price target raised to $46 from $39 at Argus
Argus analyst Stephen Biggar raised his price target on Blackstone to $46 and kept his Buy rating after its Investor Day presentation on Friday, citing the company's outlined plans to grow its assets under management to $1T from $439B currently. The analyst states that Blackstone is seeing "sees considerable growth in real estate, private equity, infrastructure, tactical opportunities and credit assets", adding that while the $1T target is "aggressive", it is also achievable, requiring "continuing cooperative economic environment and fundraising efforts". Biggar also anticipates Blackstone's "fee-related earnings component to grow significantly over the next two years" as its flagship funds reach key milestones, helping reduce earnings volatility and yielding "more consistent" dividend payouts.
09/24/18
JMPS
09/24/18
NO CHANGE
Target $43
JMPS
Outperform
Blackstone price target raised to $43 after investor day at JMP Securities
JMP Securities analyst Devin Ryan raised his price target on Blackstone shares to $43 from $39 following the company's investor day, from which he said the primary takeaway was the company's detailed roadmap for growth to $1T+ of AUM over the next eight years from $439B of total assets today. Ryan, who said Blackstone communicated a "clear line of sight" into $2 of fee-related earnings over the longer-term, keeps an Outperform rating on Blackstone shares.
CBOE Cboe Global Markets
$111.90

-0.37 (-0.33%)

09/05/18
RSBL
09/05/18
INITIATION
Target $115
RSBL
Buy
Cboe Global Markets initiated with a Buy at Rosenblatt
Rosenblatt analyst Ken Hill initiated Cboe Global Markets with a Buy and $115 price target saying to own shares for a rebound in volatility and index trading activity. Hill said the backdrop for increased volumes looks more supportive and sees potential for Cboe shares to outperform as results recover and sentiment improves.
09/07/18
WELS
09/07/18
NO CHANGE
Target $115
WELS
Outperform
Cboe risk/reward attractive heading into fall, says Wells Fargo
Wells Fargo analyst Christopher Harris believes the VIX complex volumes bottomed in August, creating and attractive risk/reward for shares of Cboe Global Markets (CBOE) heading into the fall. Supporting data include steadily rising open interest trends, recent improvement in volume trends and better VIX exchange-traded product flows, Harris tells investors in a research note. In addition, Cboe's relative valuation versus CME Group (CME) "has rarely been this low," the analyst adds. He keeps an Outperform rating on Cboe Global Markets with a $115 price target.
07/09/18
COMP
07/09/18
INITIATION
Target $115
COMP
Buy
Cboe Global Markets initiated with a Buy at Compass Point
Compass Point initiated Cboe Global Markets with a Buy and $115 price target.
08/20/18
RAJA
08/20/18
UPGRADE
RAJA
Outperform
Cboe Global Markets upgraded to Outperform from Market Perform at Raymond James
C Citi
$67.30

1.4 (2.12%)

08/28/18
WELS
08/28/18
NO CHANGE
Target $100
WELS
Outperform
Citi to benefit from potential U.S.-Mexico trade deal, says Wells Fargo
Wells Fargo analyst Mike Mayo believes Citi could gain more than other large U.S. banks from a U.S.-Mexico trade deal given its ownership of the second largest bank in Mexico, Citibanamex. In his view, Citi's stock had been hurt on perceptions of the U.S. relationship with Mexico. At a minimum, any new trade deal could reflect the absence of a negative and, on the upside, new potential growth opportunities, he contends. Mayo reiterates an Outperform rating and $100 price target on the shares.
10/15/18
BMOC
10/15/18
NO CHANGE
Target $92
BMOC
Market Perform
Citi price target raised to $92 from $85 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on Citi to $92 in spite of its Q3 earnings miss as he rolls his valuation model forward by a quarter. The analyst also notes that its lower expected revenues are being offset by lower costs while pointing to "cheap" valuation for financials in spite of the rising interest rates which are positive for net interest margins and better employment which is positive for credit. Fotheringham keeps his Market Perform rating for Citi, stating that some of its peers offer an even "greater opportunity".
09/25/18
WOLF
09/25/18
INITIATION
Target $91
WOLF
Outperform
Citi initiated with an Outperform at Wolfe Research
Wolfe Research analyst Steven Chubak initiated Citi with an Outperform and $91 price target.
AXP American Express
$105.20

1.51 (1.46%)

10/19/18
OPCO
10/19/18
NO CHANGE
Target $111
OPCO
Outperform
Oppenheimer remains a buyer of American Express after Q3 results
Oppenheimer analyst Dominick Gabriele said he remains a buyer of American Express following the company's "robust" results, which were driven by billed business growth that accelerated to 10% from 9% y/y. The EPS beat of $1.88 came from better provision expense vs. estimates while pre-provision earnings was in line, Gabriele tells investors in a research note. He maintains an Outperform rating and $111 price target.
10/19/18
SPHN
10/19/18
NO CHANGE
Target $131
SPHN
Overweight
Stephens impressed by American Express performance, encouraged by partnerships
Stephens analyst Vincent Caintic said he was "impressed" by American Express' Q3 performance after the company reported results and raised guidance for revenue growth, margins and credit reserving. He is also "encouraged" by its partnerships with PayPal (PYPL) and Amazon Small Business (AMZN), Caintic tells investors in a post-earnings research note. The analyst, who expects AmEx's billed business and revenue growth to accelerate from 10% in 2018, keeps an Overweight rating and $131 price target on the shares.
10/19/18
RBCM
10/19/18
NO CHANGE
Target $91
RBCM
Underperform
RBC remains concerned about American Express competition despite Q3 beat
RBC Capital analyst Jason Arnold attributes lower provisions and expenses, as opposed to more robust revenues, for American Express' Q3 outperformance and he remains concerned that competition will weigh on growth and returns going forward. While raising his 2018 and 2019 EPS estimates "slightly" drives his price target up to $91 from $87, Arnold keeps an Underperform rating on AmEx shares.
KKR KKR
$24.00

0.13 (0.54%)

10/18/18
MZHO
10/18/18
NO CHANGE
Target $37
MZHO
Neutral
Mizuho sees maximum Acadia leveraged buyout price at $48 per share
Mizuho analyst Ann Hynes reiterates this morning that her model suggests Acadia Healthcare's (ACHC) maximum leveraged buyout take-out price is $48.00 per share given its current debt levels. The stock in premarket trading is up 8%, or $3.32, to $39.00 after Reuters reported that the company is in talks with private equity firms about selling itself after attracting buyout interest. KKR (KKR) and TPG Global are among the private equity firms that have approached Acadia, according to Reuters. Hynes keeps a Neutral rating on Acadia shares with a $37 price target.
10/26/18
ARGS
10/26/18
UPGRADE
ARGS
Buy
KKR upgraded to Buy from Hold at Argus
10/18/18
LEER
10/18/18
NO CHANGE
LEER
Acadia may receive 11-12 times multiple in private equity takeout, says Leerink
Following reports saying KKR (KKR) and TPG Global are reportedly in talks with Acadia (ACHC) on a take-private deal, Leerink analyst Ana Gupte notes that private equity has always been interested in the company given its addiction treatment centers acquired through CRC Health and outpatient focus on eating disorders and substance abuse, though the multiples at which a takeout would be acceptable to Acadia's management were unclear. The analyst expects the recent news flow on understaffing and quality of service delivery at Acadia in the short news report may be driving more willingness to entertain such a take private of the company. Gupte believes a 11-12 times multiple is likely and represents upside of about 35%-55% on the current $35 per share trading price.
10/26/18
ARGS
10/26/18
UPGRADE
Target $28
ARGS
Buy
KKR upgraded to Buy at Argus on valuation
As reported earlier, Argus analyst Stephen Biggar upgraded KKR to Buy from Hold with a price target of $28. The analyst says the pullback in the company's stock price is unwarranted, with its latest Q3 earnings beating expectations amid "continued healthy growth in fees and performance-related income". Biggar adds that the recent "market turbulence" will offer the company opportunities to deploy its "substantial cash holdings" in assets with future monetizations. The analyst further stated that its valuation premium to other alternative asset managers is "warranted by KKR's greater liquidity following its conversion to corporate status".
JPM JPMorgan
$109.08

0.79 (0.73%)

10/16/18
JANY
10/16/18
NO CHANGE
JANY
Buy
Janney Montgomery Scott says On Deck's new unit hints at new bank partnerships
After On Deck Capital (ONDK) announced earlier that it has created a new wholly owned subsidiary, ODX, that will provide technology and other services to banks looking to lend online to small businesses, Janney Montgomery Scott analyst John Rowan said he sees this as the logical step before the company announces one or more new bank partnerships. While he thinks the company's lone existing bank partnership, with JPMorgan (JPM), is not a profit center, Rowan believes that the economics could improve as each new bank partner comes on-board and he thinks ODX could eventually become a profit center for On Deck. He maintains a Buy rating on the stock.
10/15/18
BMOC
10/15/18
NO CHANGE
Target $124
BMOC
Market Perform
JPMorgan price target raised to $124 from $118 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on JPMorgan to $124 after its Q3 earnings beat driven by lower than expected loan loss provision. The analyst notes that financials are "cheap again" in spite of the rising interest rates which are positive for net interest margins, better employment which is positive for credit, and regulatory relief which is positive for their capital position. Fotherinham also keeps his Market Perform rating on JPMorgan, saying its two-year forward earnings multiple is "only slightly" below its long-term historical average.
10/03/18
BERN
10/03/18
NO CHANGE
BERN
Amazon to be accelerant of disruption coming for healthcare, says Bernstein
Bernstein analyst Lance Wilkes believes disruption is coming for healthcare and that Amazon (AMZN) will be an accelerant of this disruption. Further, the analyst sees a parallel with the fast changes in health insurance which took place in the 90's, when health insurance changed from 90% indemnity to 80% managed care within ten years. Wilkes thinks Amazon is developing a series of business strategies for entering healthcare market segments, namely directly entering online pharmacy, creating a disruptor in the employer healthcare space through its venture with Berkshire (BRK.A) and JPMorgan (JPM), and entering digital consumer healthcare spaces including using Alexa for consumer engagement and behavior modification.
09/25/18
WOLF
09/25/18
INITIATION
Target $140
WOLF
Outperform
JPMorgan initiated with an Outperform at Wolfe Research
Wolfe Research analyst Steven Chubak initiated JPMorgan with an Outperform and $140 price target.
MS Morgan Stanley
$45.82

-0.12 (-0.26%)

10/24/18
10/24/18
UPGRADE
Target $60

Outperform
Wells Fargo goes 'all-in' on U.S. global banks, ups Morgan Stanley to Outperform
As previously reported, Wells Fargo analyst Mike Mayo upgraded Morgan Stanley (MS) to Outperform from Market Perform, noting that this means he now recommends 5 out of 5 of the largest U.S. wholesale banks. Morgan Stanley has evolved its business mix more than any other large bank, having increased its wealth and asset management to half of the firm, said Mayo, who sees the bank's EPS beating consensus by 2020 even assuming only 5% total revenue growth over that period. Mayo expects Morgan Stanley to increase its financial targets in January and believes it should fare better under the next CCAR in June, he added. Mayo raised his price target on Morgan Stanley shares to $60 from $56.
10/16/18
OPCO
10/16/18
UPGRADE
Target $62
OPCO
Outperform
Oppenheimer upgrades Morgan Stanley to Outperform after 'clean beat'
Oppenheimer analyst Chris Kotowski upgraded Morgan Stanley to Outperform from Perform with a $62 price target following this morning's Q3 results. The stock in morning trading is up 4%, or $1.67, to $45.13. Morgan Stanley continues to perform well, "and the market has not cared about this," Kotowski tells investors in a research note titled "Stock Down, Earnings Up!" The analyst views the Q3 report as a "clean beat" and upped his 2019 earnings per share estimate to $5.17 from $5.04 as a result. Despite a string of estimate upticks, shares of Morgan Stanley are down 25% since early March, Kotowski points out. He thinks the market's attitude that it is late in the cycle and that financial stocks "are not safe at any price" will prove wrong.
10/24/18
10/24/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Lockheed Martin (LMT) upgraded to Conviction Buy from Neutral at Goldman Sachs with analyst Noah Poponak raising his price target for the shares to $394 from $391. 2. Paccar (PCAR) upgraded to Overweight from Neutral at Piper Jaffray with analyst Alexander Potter saying Paccar's brands boasted the highest level of brand loyalty in his firm's survey of 743 U.S.-based fleets. 3. Morgan Stanley (MS) upgraded to Outperform from Market Perform at Wells Fargo with analyst Mike Mayo saying this means he now recommends 5 out of 5 of the largest U.S. wholesale banks. 4. 3D Systems (DDD) upgraded to Neutral from Underweight at Piper Jaffray with analyst Troy Jensen saying while Piper's Q3 survey "showed another poor performance" from 3D Systems' resellers, the company's "significant direct sales win" with Align Technology (ALGN) will continue to allow 3D Systems to report "impressive" year-over-year product growth for the next few quarters. 5. Lululemon (LULU) upgraded to Buy from Hold at Canaccord with analyst Camilo Lyon saying he recommends taking advantage of the recent 15% pullback as he believes the risk/reward is now skewed to the upside. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/24/18
WELS
10/24/18
UPGRADE
WELS
Outperform
Morgan Stanley upgraded to Outperform from Market Perform at Wells Fargo
FRC First Republic
$92.91

0.71 (0.77%)

11/05/18
JPMS
11/05/18
NO CHANGE
Target $111
JPMS
Overweight
First Republic added to Analyst Focus List at JPMorgan
JPMorgan analyst Steven Alexopoulos added First Republic to his firm's Analyst Focus list after holding investor meetings with senior management. The analyst sees the company's "service moat as further widening" in the "digital age of banking that lies ahead." First Republic's sales growth prospects "have never been this strong," Alexopoulos tells investors in a research note. He increasingly sees capital flows "being directed into higher quality franchises, such as First Republic." The analyst keeps an Overweight rating on the shares with a $111 price target.
07/16/18
BMOC
07/16/18
NO CHANGE
Target $102
BMOC
Market Perform
First Republic price target raised to $102 from $96 at BMO Capital
BMO Capital analyst Lana Chan raised her price target on First Republic to $102 after its Q2 earnings beat that was driven "solely by a lower tax rate". Chan notes that while the company continues to generate "impressive" growth in lending, deposits, and assets under management, the positive developments are already reflected in its "5-multiple premium to smid-cap peers". The analyst keeps her Market Perform rating on First Republic.
09/13/18
RBCM
09/13/18
NO CHANGE
Target $102
RBCM
Sector Perform
First Republic price target raised to $102 from $97 at RBC Capital
RBC Capital analyst Jon Arfstrom raised his price target on First Republic to $102 as part of his model "fine tuning" following the bank's common equity offering. The analyst says the capital raise was "consistent" with its continued growth strategy and outlook, adding the management has been "disciplined and conservative" with its capital strategy. Arfstrom adds that he still views First Republic as a "very high quality core holding for long term investors" but keeps his Sector Perform rating, saying the stance reflects the bank's valuation relative to its peers.
06/26/18
WELS
06/26/18
NO CHANGE
Target $100
WELS
Market Perform
First Republic price target raised to $100 from $95 at Wells Fargo
Wells Fargo analyst Jared Shaw raised his price target for First Republic to $100 from $95 heading into Q2 as he believes the banking industry continues to benefit from a level of structural tailwinds he has not seen in over a decade. The analyst reiterates a Market Perform rating on the shares.
EV Eaton Vance
$44.71

-0.7 (-1.54%)

05/02/18
05/02/18
UPGRADE
Target $63

Buy
Eaton Vance upgraded to Buy on growth potential at BofA/Merrill
As previously reported, BofA/Merrill upgraded Eaton Vance to Buy and raised its price target to $63 from $61. Analyst Michael Carrier believes Eaton Vance is poised to deliver "superior organic growth" in a rising rate environment and expects margins to rise from attractive product mix. Further, the analyst sees meaningful potential in Calvert, ample room for growth internationally, and views valuation as attractive.
05/02/18
BOFA
05/02/18
UPGRADE
BOFA
Buy
Eaton Vance upgraded to Buy from Neutral at BofA/Merrill

TODAY'S FREE FLY STORIES

JD

JD.com

$23.04

-1.18 (-4.87%)

, SPB

Spectrum Brands

$59.36

0.87 (1.49%)

20:25
11/18/18
11/18
20:25
11/18/18
20:25
Earnings
Notable companies reporting before Monday's open »

Notable companies…

JD

JD.com

$23.04

-1.18 (-4.87%)

SPB

Spectrum Brands

$59.36

0.87 (1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

AAPL

Apple

$193.42

2 (1.04%)

, PCG

PG&E

$24.39

6.62 (37.25%)

19:29
11/18/18
11/18
19:29
11/18/18
19:29
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

AAPL

Apple

$193.42

2 (1.04%)

PCG

PG&E

$24.39

6.62 (37.25%)

CBS

CBS

$57.49

0.23 (0.40%)

VIA

Viacom

$37.05

0.96 (2.66%)

VIAB

Viacom

$33.00

1.13 (3.55%)

AMZN

Amazon.com

$1,593.59

-26.41 (-1.63%)

KSS

Kohl's

$72.48

-0.7 (-0.96%)

TGT

Target

$79.67

-1.09 (-1.35%)

HD

Home Depot

$177.11

-0.25 (-0.14%)

TIF

Tiffany

$106.48

0.52 (0.49%)

BBY

Best Buy

$66.41

-1.34 (-1.98%)

TJX

TJX

$51.47

-0.98 (-1.87%)

JCP

J.C. Penney

$1.29

-0.08 (-5.84%)

LB

L Brands

$35.28

-0.41 (-1.15%)

T

AT&T

$30.30

0.18 (0.60%)

BP

BP

$40.85

-0.3 (-0.73%)

CVX

Chevron

$119.14

2.18 (1.86%)

XOM

Exxon Mobil

$78.99

0.81 (1.04%)

RDS.A

Royal Dutch Shell

$62.02

0.34 (0.55%)

RDS.B

Royal Dutch Shell

$63.97

0.19 (0.30%)

APC

Anadarko

$56.39

0.9 (1.62%)

EOG

EOG Resources

$105.21

3.57 (3.51%)

OXY

Occidental Petroleum

$73.32

0.71 (0.98%)

COG

Cabot Oil & Gas

$25.73

0.09 (0.35%)

EQT

EQT Corporation

$16.62

-0.55 (-3.20%)

HAL

Halliburton

$32.46

0.02 (0.06%)

SLB

Schlumberger

$48.24

0.17 (0.35%)

AMGN

Amgen

$194.23

1.83 (0.95%)

THS

TreeHouse

$51.92

0.72 (1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 26

    Nov

  • 27

    Nov

  • 28

    Nov

  • 01

    Dec

  • 02

    Dec

  • 03

    Dec

  • 03

    Dec

  • 03

    Dec

  • 04

    Dec

  • 04

    Dec

  • 05

    Dec

  • 18

    Jan

  • 22

    Jan

  • 03

    Mar

ZAYO

Zayo Group

$23.70

1.495 (6.73%)

, BX

Blackstone

$32.48

-0.02 (-0.06%)

18:50
11/18/18
11/18
18:50
11/18/18
18:50
Periodicals
Zayo said to get interest from Blackstone-Stonepeak Group, Bloomberg reports »

Zayo (ZAYO) has attracted…

ZAYO

Zayo Group

$23.70

1.495 (6.73%)

BX

Blackstone

$32.48

-0.02 (-0.06%)

KKR

KKR

$21.83

-0.46 (-2.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 03

    Dec

PCG

PG&E

$24.39

6.62 (37.25%)

18:08
11/18/18
11/18
18:08
11/18/18
18:08
Periodicals
PG&E reports another outage on morning when California started, Reuters says »

PG&E, facing investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KL

Kirkland Lake Gold

$18.97

0.28 (1.50%)

18:04
11/18/18
11/18
18:04
11/18/18
18:04
Hot Stocks
Kirkland Lake Gold appoints David Soares as CFO, Eric Kallio as senior VP »

Kirkland Lake Gold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXPD

Expeditors

$73.67

0.14 (0.19%)

17:19
11/18/18
11/18
17:19
11/18/18
17:19
Conference/Events
Expeditors management to meet with Wolfe Research »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

CBS

CBS

$57.49

0.23 (0.40%)

, VIAB

Viacom

$33.00

1.13 (3.55%)

16:54
11/18/18
11/18
16:54
11/18/18
16:54
Periodicals
CBS, Viacom merger could be a few months away, NY Post reports »

After CBS (CBS) CEO Les…

CBS

CBS

$57.49

0.23 (0.40%)

VIAB

Viacom

$33.00

1.13 (3.55%)

VIA

Viacom

$37.05

0.96 (2.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 04

    Dec

AIMT

Aimmune

$29.61

0.05 (0.17%)

16:51
11/18/18
11/18
16:51
11/18/18
16:51
Hot Stocks
PALISADE trial of Aimmune's AR101 published in New England Journal of Medicine »

Aimmune Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 12

    Dec

T

AT&T

$30.30

0.18 (0.60%)

, CMCSA

Comcast

$38.60

0.11 (0.29%)

16:31
11/18/18
11/18
16:31
11/18/18
16:31
Hot Stocks
Box Office Battle: 'Fantastic Beasts 2' wins weekend with $62M »

AT&T (T) subsidiary…

T

AT&T

$30.30

0.18 (0.60%)

CMCSA

Comcast

$38.60

0.11 (0.29%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$50.80

-0.81 (-1.57%)

FOX

21st Century Fox

$47.73

-0.1 (-0.21%)

FOXA

21st Century Fox

$48.18

-0.11 (-0.23%)

LGF.A

Lionsgate

$20.88

0.365 (1.78%)

DIS

Disney

$116.20

-0.9 (-0.77%)

VIAB

Viacom

$33.00

1.13 (3.55%)

VIA

Viacom

$37.05

0.96 (2.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 04

    Dec

VLKAY

Volkswagen

$0.00

(0.00%)

, GOOG

Alphabet

$1,062.01

-2.73 (-0.26%)

15:45
11/18/18
11/18
15:45
11/18/18
15:45
Periodicals
Volkswagen CEO says Waymo has 1/2-year head start, Reuters reports »

Volkwagen (VLKAY) is up…

VLKAY

Volkswagen

$0.00

(0.00%)

GOOG

Alphabet

$1,062.01

-2.73 (-0.26%)

GOOGL

Alphabet Class A

$1,069.13

-2.09 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 03

    Mar

T

AT&T

$30.30

0.18 (0.60%)

, FOX

21st Century Fox

$47.73

-0.1 (-0.21%)

15:21
11/18/18
11/18
15:21
11/18/18
15:21
Hot Stocks
AT&T, Fox Networks renew multi-year deal across distribution platforms »

AT&T (T) and Fox…

T

AT&T

$30.30

0.18 (0.60%)

FOX

21st Century Fox

$47.73

-0.1 (-0.21%)

FOXA

21st Century Fox

$48.18

-0.11 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 04

    Dec

AAPL

Apple

$193.42

2 (1.04%)

13:35
11/18/18
11/18
13:35
11/18/18
13:35
Periodicals
Apple CEO views new regulations as 'inevitable,' Axios reports »

Apple CEO Tim Cook says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSRGY

Nestle

$0.00

(0.00%)

, RIO

Rio Tinto

$50.94

0.89 (1.78%)

13:05
11/18/18
11/18
13:05
11/18/18
13:05
Periodicals
Nespresso, Rio Tinto joining forces to make coffee pods greener, Reuters says »

Nespresso, part of food…

NSRGY

Nestle

$0.00

(0.00%)

RIO

Rio Tinto

$50.94

0.89 (1.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNOA

Sonoma Pharmaceuticals

$1.11

-0.095 (-7.92%)

12:54
11/18/18
11/18
12:54
11/18/18
12:54
Hot Stocks
Sonoma Pharmaceuticals announces pricing of public offering of units »

Sonoma Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 04

    Dec

NVS

Novartis

$87.74

0.52 (0.60%)

, DBVT

DBV Technologies

$16.70

0.31 (1.89%)

04:55
11/18/18
11/18
04:55
11/18/18
04:55
Conference/Events
American College of Allergy, Asthma & Immunology to hold a meeting »

2018 ACAAI Meeting will…

NVS

Novartis

$87.74

0.52 (0.60%)

DBVT

DBV Technologies

$16.70

0.31 (1.89%)

REGN

Regeneron

$345.10

3.56 (1.04%)

SHPG

Shire

$175.59

-3.39 (-1.89%)

TEVA

Teva

$22.25

-0.37 (-1.64%)

SNY

Sanofi

$45.11

0.56 (1.26%)

GSK

GlaxoSmithKline

$40.35

-0.06 (-0.15%)

AZN

AstraZeneca

$40.67

-0.685 (-1.66%)

CHD

Church & Dwight

$65.42

-0.39 (-0.59%)

BSX

Boston Scientific

$37.22

0.75 (2.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 30

    Nov

  • 02

    Dec

  • 03

    Dec

  • 21

    Dec

  • 28

    Jan

  • 11

    Mar

  • 22

    Mar

  • 28

    Apr

  • 13

    May

PDVW

pdvWireless

$39.84

0.06 (0.15%)

16:30
11/17/18
11/17
16:30
11/17/18
16:30
Conference/Events
pdvWireless management to meet with Morgan Stanley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBS

CBS

$57.49

0.23 (0.40%)

16:28
11/17/18
11/17
16:28
11/17/18
16:28
Conference/Events
CBS management to meet with Morgan Stanley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

THS

TreeHouse

$51.92

0.72 (1.41%)

, CAG

Conagra Brands

$33.09

0.66 (2.04%)

12:54
11/17/18
11/17
12:54
11/17/18
12:54
Periodicals
Treehouse Foods stock may have room to gain, Barron's says »

Treehouse Foods (THS)…

THS

TreeHouse

$51.92

0.72 (1.41%)

CAG

Conagra Brands

$33.09

0.66 (2.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$194.23

1.83 (0.95%)

12:51
11/17/18
11/17
12:51
11/17/18
12:51
Periodicals
Amgen may be 'a remedy' for tougher times, Barron's says »

Amgen may be a stock that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 01

    Dec

  • 02

    Dec

  • 03

    Dec

  • 03

    Dec

AAPL

Apple

$193.42

2 (1.04%)

, LITE

Lumentum

$41.50

0.46 (1.12%)

12:47
11/17/18
11/17
12:47
11/17/18
12:47
Periodicals
Apple stock could continue to slide, Barron's says »

Apple's (AAPL) stock…

AAPL

Apple

$193.42

2 (1.04%)

LITE

Lumentum

$41.50

0.46 (1.12%)

QRVO

Qorvo

$66.32

1.18 (1.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$56.39

0.9 (1.62%)

, RDS.B

Royal Dutch Shell

$63.97

0.19 (0.30%)

12:41
11/17/18
11/17
12:41
11/17/18
12:41
Periodicals
Investors may find bargains among oil, natural gas stocks, Barron's says »

Investors have been…

APC

Anadarko

$56.39

0.9 (1.62%)

RDS.B

Royal Dutch Shell

$63.97

0.19 (0.30%)

RDS.A

Royal Dutch Shell

$62.02

0.34 (0.55%)

XOM

Exxon Mobil

$78.99

0.81 (1.04%)

CVX

Chevron

$119.14

2.18 (1.86%)

BP

BP

$40.85

-0.3 (-0.73%)

EOG

EOG Resources

$105.21

3.57 (3.51%)

OXY

Occidental Petroleum

$73.32

0.71 (0.98%)

COG

Cabot Oil & Gas

$25.73

0.09 (0.35%)

EQT

EQT Corporation

$16.62

-0.55 (-3.20%)

HAL

Halliburton

$32.46

0.02 (0.06%)

SLB

Schlumberger

$48.24

0.17 (0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 18

    Jan

  • 22

    Jan

LB

L Brands

$35.28

-0.41 (-1.15%)

, JCP

J.C. Penney

$1.29

-0.08 (-5.84%)

12:34
11/17/18
11/17
12:34
11/17/18
12:34
Periodicals
Kohl's, Target set to thrive this holiday season, Barron's says »

Store chains have been…

LB

L Brands

$35.28

-0.41 (-1.15%)

JCP

J.C. Penney

$1.29

-0.08 (-5.84%)

TJX

TJX

$51.47

-0.98 (-1.87%)

BBY

Best Buy

$66.41

-1.34 (-1.98%)

TIF

Tiffany

$106.48

0.52 (0.49%)

HD

Home Depot

$177.11

-0.25 (-0.14%)

TGT

Target

$79.67

-1.09 (-1.35%)

KSS

Kohl's

$72.48

-0.7 (-0.96%)

AMZN

Amazon.com

$1,593.59

-26.41 (-1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 28

    Nov

  • 04

    Dec

  • 05

    Dec

  • 03

    Mar

T

AT&T

$30.30

0.18 (0.60%)

, FOX

21st Century Fox

$47.73

-0.1 (-0.21%)

09:18
11/17/18
11/17
09:18
11/17/18
09:18
OnTheFly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

T

AT&T

$30.30

0.18 (0.60%)

FOX

21st Century Fox

$47.73

-0.1 (-0.21%)

FOXA

21st Century Fox

$48.18

-0.11 (-0.23%)

AMZN

Amazon.com

$1,593.59

-26.41 (-1.63%)

CMCSA

Comcast

$38.60

0.11 (0.29%)

CMCSK

Comcast

$0.00

(0.00%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$16.46

-0.12 (-0.72%)

F

Ford

$9.05

-0.26 (-2.79%)

GM

General Motors

$35.76

0.21 (0.59%)

HMC

Honda

$28.21

0.01 (0.04%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$116.87

-0.02 (-0.02%)

VLKAY

Volkswagen

$0.00

(0.00%)

NYT

New York Times

$26.30

-0.2 (-0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 03

    Dec

  • 04

    Dec

  • 13

    Dec

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

NVS

Novartis

$87.74

0.52 (0.60%)

, DBVT

DBV Technologies

$16.70

0.31 (1.89%)

04:55
11/17/18
11/17
04:55
11/17/18
04:55
Conference/Events
American College of Allergy, Asthma & Immunology to hold a meeting »

2018 ACAAI Meeting will…

NVS

Novartis

$87.74

0.52 (0.60%)

DBVT

DBV Technologies

$16.70

0.31 (1.89%)

REGN

Regeneron

$345.10

3.56 (1.04%)

SHPG

Shire

$175.59

-3.39 (-1.89%)

TEVA

Teva

$22.25

-0.37 (-1.64%)

SNY

Sanofi

$45.11

0.56 (1.26%)

GSK

GlaxoSmithKline

$40.35

-0.06 (-0.15%)

AZN

AstraZeneca

$40.67

-0.685 (-1.66%)

CHD

Church & Dwight

$65.42

-0.39 (-0.59%)

BSX

Boston Scientific

$37.22

0.75 (2.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 30

    Nov

  • 02

    Dec

  • 03

    Dec

  • 21

    Dec

  • 28

    Jan

  • 11

    Mar

  • 22

    Mar

  • 28

    Apr

  • 13

    May

MSI

Motorola Solutions

$129.97

0.72 (0.56%)

18:48
11/16/18
11/16
18:48
11/16/18
18:48
Hot Stocks
Motorola Solutions: ITC confirms Hytera products infringe Motorola patents »

Motorola Solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 18

    Dec

  • 19

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.